Moderna Says It Has $18.5 Billion in Vaccine Orders for 2022
- More sales deals likely as talks continue, CEO tells Bloomberg
- Product sales were $17.5 billion in 2021, beating estimates
This article is for subscribers only.
Moderna Inc. said it has signed vaccine purchase agreements worth $18.5 billion for this year, along with options for another $3.5 billion, including booster shots.
In a statement on Monday, the company also said 2021 product sales would be $17.5 billion, slightly higher than the average analyst estimate of $17 billion, according to data compiled by Bloomberg. Additionally, the company said that it shipped 807 million vaccine doses in 2021. Previously, it had said it would deliver between 700 milion and 800 million doses.